Hemab Therapeutics Holdings Inc（COAG）價格預測

$34.400

-0.409 (-1.19%)收盤時

價格預測

1-Day Price Prediction

+2.82%

1-Week Prediction

-0.98%

1-Month Prediction

—

2026 Prediction

—

2030 Prediction

—

在 App 中開啟以解鎖更長週期的預測。

Loading chart…

COAG 相似圖表分析預測

Alphio's COAG stock price prediction model matches the current Hemab Therapeutics Holdings Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $35.37 (+2.82%). The 1-week path is $34.06 (-0.98%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

該買進 Hemab Therapeutics Holdings Inc 股票嗎？

Currently, Hemab Therapeutics Holdings, Inc. (COAG) is not a strong buy due to its recent performance and financial metrics. The stock closed at $30.07, down 4.90% over the last five days and 27.00% over the last 20 days. While the analyst consensus price target is $62.42, suggesting a potential upside of 105.68%, the company has reported significant net losses, with a net income of -24,150,000 USD in Q2 2026 and an EPS of -0.52. The RSI is at 42.221, indicating the stock is nearing oversold conditions, but the overall trend remains negative. Therefore, it may be prudent to hold rather than buy at this moment, as the stock may need time to stabilize and recover from its recent declines.